Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
Article in British Journal of Cancer (February 2022)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in British Journal of Cancer (February 2022)
Article in Future Oncology (November 2019)
Article in Reactions Weekly (August 2014)